Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constantin N Baxevanis

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Expert Review of Vaccines|March 3, 2012
Outlining novel scenarios for improved therapeutic cancer vaccines: the PANVAC paradigmConstantin N Baxevanis
Expert Opinion on Drug Discovery|March 16, 2013
Antibody-based cancer therapyConstantin N Baxevanis
Cancer Immunology, Immunotherapy : CII|April 8, 2019
T-cell recognition of non-mutated tumor antigens in healthy individuals: connecting endogenous immunity and tumor dormancyConstantin N Baxevanis
Cancers|February 11, 2023
Immune Checkpoint Inhibitors in Cancer Therapy-How Can We Improve Clinical Benefits?Constantin N Baxevanis
Cancers|March 29, 2023
Biomarkers in the Era of Precision OncologyConstantin N Baxevanis
Cancer Immunology, Immunotherapy : CII|May 29, 2004
Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genesConstantin N Baxevanis, Michael Papamichail
Cancer Immunology, Immunotherapy : CII|January 13, 2006
Fifth European progress in vaccination against cancer conference, PIVAC 5Federica Cavallo, Constantin N Baxevanis
Vaccines|September 10, 2015
Cancer Dormancy: A Regulatory Role for Endogenous Immunity in Establishing and Maintaining the Tumor Dormant StateConstantin N Baxevanis, Sonia A Perez
Expert Review of Vaccines|January 23, 2016
Cancer vaccines: limited success but the research should remain viableConstantin N Baxevanis, Sonia A Perez
Future Science OA|December 30, 2016
Endogenous immunity at the forefront of tumor dormancyConstantin N Baxevanis, Sonia A Perez
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Expert Review of Vaccines|March 3, 2012
Outlining novel scenarios for improved therapeutic cancer vaccines: the PANVAC paradigmConstantin N Baxevanis
Expert Opinion on Drug Discovery|March 16, 2013
Antibody-based cancer therapyConstantin N Baxevanis
Cancer Immunology, Immunotherapy : CII|April 8, 2019
T-cell recognition of non-mutated tumor antigens in healthy individuals: connecting endogenous immunity and tumor dormancyConstantin N Baxevanis
Cancers|February 11, 2023
Immune Checkpoint Inhibitors in Cancer Therapy-How Can We Improve Clinical Benefits?Constantin N Baxevanis
Cancers|March 29, 2023
Biomarkers in the Era of Precision OncologyConstantin N Baxevanis
Cancer Immunology, Immunotherapy : CII|May 29, 2004
Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genesConstantin N Baxevanis, Michael Papamichail
Cancer Immunology, Immunotherapy : CII|January 13, 2006
Fifth European progress in vaccination against cancer conference, PIVAC 5Federica Cavallo, Constantin N Baxevanis
Vaccines|September 10, 2015
Cancer Dormancy: A Regulatory Role for Endogenous Immunity in Establishing and Maintaining the Tumor Dormant StateConstantin N Baxevanis, Sonia A Perez
Expert Review of Vaccines|January 23, 2016
Cancer vaccines: limited success but the research should remain viableConstantin N Baxevanis, Sonia A Perez
Future Science OA|December 30, 2016
Endogenous immunity at the forefront of tumor dormancyConstantin N Baxevanis, Sonia A Perez
Pageof 12